Who we are

Founders

Investors

Team

Advisors

Announcing Achira

Update: Achira has secured $33M from Dimension, Amplify, NVIDIA, and Compound.

Achira is building atomistic foundation simulation models to power the future of drug discovery.

We are a team of machine learners, quantum chemists, engineers, and computer-aided drug discovery practitioners united by the ambition to create a fundamentally new way of discovering therapeutic compounds.

Achira is founded in the belief that contemporary approaches to biomolecular simulation are technologically limited and ill-suited to harness the hundred-billion-fold increase in computing power that followed their development. Pure machine learning models, in contrast, are significantly limited by the paucity and cost of acquisition of drug discovery data.

We are pioneering a third path.

We are creating a new class of simulation models that blend geometric deep learning, physics, quantum chemistry, and statistical mechanics into advanced potentials and generative models to deliver unprecedented performance across a diverse set of biomolecular applications. By scaling simulation models to build large, accurate synthetic datasets free of experimental artifacts, we unlock the potential for generative models to transform drug discovery into a true inverse design problem. This vision requires harmonization of the theoretical and the pragmatic.

. . .

If you are a scientist or engineer with an uncompromising drive to build the foundational, technological substrate for biomolecular discovery and design interested in joining the team, or a drug discovery scientist interested in partnering with us to access the next generation of foundation simulation models, we encourage you to contact us.